A recent CBS News article noted an important milestone in the fight against Alzheimer’s: the first blood test to diagnose it has hit the market. The test was developed by C2N Diagnostics in St. Louis, and the founders are doctors from Washington University School of Medicine. It costs $1,250 and produces results in about 10 days, but the company offers discounts based on income. While the test aims to provide patients with easier diagnoses, the facts that key test results have yet to be published, and the test isn’t FDA approved raise accuracy concerns.
First Alzheimer’s Test Hit Market Sans FDA Approval
The new blood test costs about 75% less than current brain scans.
Dec 2, 2020
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.
REGISTER NOW & SAVE!
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More